To Assess Safety, Tolerability and Efficacy of LJN452 in Patients With Primary Bile Acid Diarrhea.
Clinical trial NCT02713243 · COMPLETED
Trial details
- NCT number
- NCT02713243
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-16
- Primary completion
- 2018-01-25
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.